FARRELL PETER C
SEC CIK 1186102 · EDGAR
BoughtSold
Most active insiders at RMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Farrell Michael J. | COB, CEO, Dir | — | $15.74M |
| 2 | FARRELL PETER C | Dir | — | $5.01M |
| 3 | Sandercock Brett | CFO | — | $2.79M |
| 4 | De Witte Jan | Dir | — | $645.9K |
| 5 | Rider Michael J | Gbl GC | — | $64.7K |
| 6 | Mowad-Nassar Nicole | Dir | — | — |
| 7 | Hernandez John | Dir | — | — |
| 8 | Tan Desney | Dir | — | — |
| 9 | DelOrefice Christopher | Dir | — | — |
| 10 | Leong Justin | Chief Product Off | — | — |
Transactions 40
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-04 06:30 | 2026-09-02 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $234.73 | -970 | 51.8K | -2% | -$227.7K |
| T | 2026-08-06 14:29 | 2026-08-05 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $225.00 | -8,000 | 52.8K | -13% | -$1.80M |
| T | 2026-04-02 13:52 | 2026-04-01 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $225.00 | -2,000 | 60.8K | -3% | -$450.0K |
| 2026-03-05 | 2026-03-04 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $260.22 | -2,000 | 62.8K | -3% | -$520.4K | |
| 2026-02-06 | 2026-02-04 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $251.31 | -2,000 | 64.8K | -3% | -$502.6K | |
| 2026-01-09 | 2026-01-07 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $248.83 | -2,000 | 66.8K | -3% | -$497.7K | |
| 2025-12-04 | 2025-12-03 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $251.47 | -2,000 | 68.8K | -3% | -$502.9K | |
| 2025-11-24 | 2025-11-20 | RMD | ResMed| | FARRELL PETER C | Dir | A - Grant | $0.00 | +536 | 70.8K | +0.8% | $0 | |
| D | 2025-11-18 | 2025-11-14 | RMD | ResMed| | FARRELL PETER C | Dir | M - OptEx | $101.64 | +11.4K | 77.6K | +17% | +$1.16M |
| D | 2025-11-18 | 2025-11-14 | RMD | ResMed| | FARRELL PETER C | Dir | F - Tax | $244.46 | -7,314 | 70.2K | -9% | -$1.79M |
| 2025-11-13 | 2025-11-11 | RMD | ResMed| | FARRELL PETER C | Dir | F - Tax | $250.10 | -162.95 | 68.1K | -0.2% | -$40.8K | |
| 2025-11-13 | 2025-11-12 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $252.05 | -2,000 | 66.1K | -3% | -$504.1K | |
| 2025-07-03 | 2025-07-02 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $255.49 | -945 | 68.3K | -1% | -$241.4K | |
| 2025-06-06 | 2025-06-04 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $247.32 | -2,000 | 69.2K | -3% | -$494.6K | |
| 2025-05-08 | 2025-05-07 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $242.25 | -2,000 | 71.2K | -3% | -$484.5K | |
| 2025-04-04 | 2025-04-02 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $219.74 | -2,000 | 73.2K | -3% | -$439.5K | |
| 2025-03-06 | 2025-03-05 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $227.71 | -2,000 | 75.2K | -3% | -$455.4K | |
| 2025-02-05 | 2025-02-05 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $242.11 | -2,000 | 77.2K | -3% | -$484.2K | |
| 2025-01-03 | 2025-01-02 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $230.99 | -2,000 | 79.2K | -2% | -$462.0K | |
| 2024-12-05 | 2024-12-04 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $245.65 | -2,000 | 81.2K | -2% | -$491.3K | |
| 2024-11-22 | 2024-11-20 | RMD | ResMed| | FARRELL PETER C | Dir | A - Grant | $0.00 | +542 | 83.2K | +0.7% | $0 | |
| 2024-11-12 | 2024-11-11 | RMD | ResMed| | FARRELL PETER C | Dir | F - Tax | $252.38 | -527.91 | 82.7K | -0.6% | -$133.2K | |
| 2024-11-08 | 2024-11-06 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $248.74 | -2,000 | 83.2K | -2% | -$497.5K | |
| 2024-10-02 | 2024-10-02 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $237.20 | -2,000 | 85.2K | -2% | -$474.4K | |
| 2024-09-06 | 2024-09-04 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $239.90 | -2,000 | 87.2K | -2% | -$479.8K | |
| D | 2024-06-18 | 2024-06-14 | ARCT | Arcturus Therapeutics Holdings Inc. | FARRELL PETER C | Dir | M - OptEx | $0.00 | +3,131 | 55.7K | +6% | $0 |
| 2024-05-17 | 2024-05-15 | RMD | ResMed| | FARRELL PETER C | Dir | G - Gift | $0.00 | -68.2K | 89.2K | -43% | $0 | |
| M | 2024-02-23 | 2023-05-03+ | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $211.84 | -23.5K | 166.9K | -12% | -$4.99M |
| 2023-11-20 | 2023-11-16 | RMD | ResMed| | FARRELL PETER C | Dir | A - Grant | $0.00 | +1,768 | 180.9K | +1.0% | $0 | |
| 2023-11-15 | 2023-11-13 | RMD | ResMed| | FARRELL PETER C | Dir | F - Tax | $143.60 | -325.38 | 179.2K | -0.2% | -$46.7K | |
| D | 2023-01-31 | 2023-01-27 | EOLS | Evolus, Inc. | FARRELL PETER C | Dir | A - Grant | $0.00 | +8,293 | 43.2K | +24% | $0 |
| 2022-11-18 | 2022-11-16 | RMD | ResMed| | FARRELL PETER C | Dir | A - Grant | $0.00 | +1,122 | 179.5K | +0.6% | $0 | |
| 2022-11-15 | 2022-11-11 | RMD | ResMed| | FARRELL PETER C | Dir | F - Tax | $225.18 | -128 | 178.4K | -0.1% | -$28.8K | |
| 2022-11-02 | 2022-10-31 | RMD | ResMed| | FARRELL PETER C | Dir | G - Gift | $0.00 | -4,550 | 178.5K | -2% | $0 | |
| 2022-11-02 | 2022-10-31 | RMD | ResMed| | FARRELL PETER C | Dir | S - Sale | $221.98 | -9,050 | 183.1K | -5% | -$2.01M | |
| I | 2022-09-06 | 2022-09-06 | EOLS | Evolus, Inc. | FARRELL PETER C | Dir | P - Purchase | $9.10 | +10.0K | 10.0K | New | +$91.0K |
| D | 2022-01-26 | 2022-01-24 | EOLS | Evolus, Inc. | FARRELL PETER C | Dir | A - Grant | $0.00 | +15.6K | 34.9K | +81% | $0 |
| D | 2021-11-22 | 2021-11-18 | RMD | ResMed| | FARRELL PETER C | Dir | A - Grant | $0.00 | +478 | 192.1K | +0.2% | $0 |
| 2021-11-15 | 2021-11-11 | RMD | ResMed| | FARRELL PETER C | Dir | F - Tax | $259.47 | -342 | 191.6K | -0.2% | -$88.7K | |
| 2021-08-17 | 2021-08-13 | RMD | ResMed| | FARRELL PETER C | Dir | G - Gift | $0.00 | -36.7K | 192.0K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations